Julie Leblanc
- Molecular Biology top 5%
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Epidemiology
- Co-authors
- P. Roy WalkerMarianna SikorskaM. SikorskaT. YoudaleJames F. WhitfieldCarl SmithJan FilipskiBolesław Lach
- Topics
- RNA Interference and Gene Delivery (7 papers)Cell death mechanisms and regulation (7 papers)DNA and Nucleic Acid Chemistry (5 papers)
- Cited by
- Molecular BiologyToxicologyOncology
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Julie Leblanc
42 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 142
- Molecular Biology 1.3k
- Oncology 358
- Immunology 227
- Cancer Research 186
- Epidemiology 176
Countries citing papers authored by Julie Leblanc
This map shows the geographic impact of Julie Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Leblanc more than expected).
Fields of papers citing papers by Julie Leblanc
This network shows the impact of papers produced by Julie Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Leblanc. The network helps show where Julie Leblanc may publish in the future.
Co-authorship network of co-authors of Julie Leblanc
This figure shows the co-authorship network connecting the top 25 collaborators of Julie Leblanc. A scholar is included among the top collaborators of Julie Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Leblanc. Julie Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 19 | |
| 5 | 6 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | Pertuzumab: development beyond breast cancer. | 31 |
| 11 | 38 | |
| 12 | 72 | |
| 13 | 5 | |
| 14 | 23 | |
| 15 | 16 | |
| 16 | 40 | |
| 17 | 44 | |
| 18 | 43 | |
| 19 | 84 | |
| 20 | 156 |
About Julie Leblanc
Julie Leblanc is a scholar working on Radiological and Ultrasound Technology, Aging and Modeling and Simulation, having authored 43 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Cell death mechanisms and regulation (7 papers) and DNA and Nucleic Acid Chemistry (5 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Toxicology (55 citations) and Oncology (358 citations). Julie Leblanc has collaborated with scholars based in Canada, United States and France. Frequent co-authors include P. Roy Walker, Marianna Sikorska, M. Sikorska, T. Youdale, James F. Whitfield, Carl Smith, Jan Filipski, Bolesław Lach, Valerie M. Weaver and Demetrius Matassov. Their work appears in journals such as The EMBO Journal, Biochemistry and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.